Products
Platform
Research
Market
Learn
Suven Life Sciences Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 4.70 | 2.47 | 2.69 | 3.24 | 6.61 |
| Other Income Qtr Cr | 3.78 | 0.60 | 1.22 | 1.63 | 4.04 |
| Operating Revenues Qtr | 0.92 | 1.87 | 1.47 | 1.61 | 2.57 |
Loading chart... | |||||
Operating Expenses Qtr | 80.69 | 52.62 | 45.29 | 40.82 | 54.78 |
Operating Profit Qtr | -79.77 | -50.75 | -43.82 | -39.21 | -52.21 |
EBITDA Qtr Cr | -75.99 | -50.15 | -42.60 | -37.58 | -48.17 |
Depreciation Qtr | 1.32 | 1.37 | 1.35 | 1.53 | 1.46 |
Net Profit Qtr | -77.31 | -51.52 | -43.94 | -39.12 | -49.64 |
Basic EPS Qtr | -3.48 | -2.36 | -2.02 | -1.79 | -2.27 |
Open Demat Account
Open Demat Account